Page last updated: 2024-09-04

atrasentan and abiraterone

atrasentan has been researched along with abiraterone in 1 studies

Compound Research Comparison

Studies (atrasentan)	Trials (atrasentan)	Recent Studies (post-2010) (atrasentan)	Studies (abiraterone)	Trials (abiraterone)	Recent Studies (post-2010) (abiraterone)
358	41	108	942	97	854

Protein Interaction Comparison

Protein	Taxonomy	abiraterone (IC50)
Steroid 17-alpha-hydroxylase/17,20 lyase	Homo sapiens (human)	0.2557
Cytochrome P450 3A4	Homo sapiens (human)	2.0643
Steroid 21-hydroxylase	Homo sapiens (human)	0.1642
Steroid 17-alpha-hydroxylase/17,20 lyase	Rattus norvegicus (Norway rat)	0.0674
Cytochrome P450 11B1, mitochondrial	Homo sapiens (human)	1.5714
Cytochrome P450 11B2, mitochondrial	Homo sapiens (human)	1.722

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Corn, PG; Dayyani, F; Gallick, GE; Logothetis, CJ	1

Reviews

1 review(s) available for atrasentan and abiraterone

Article	Year
Novel therapies for metastatic castrate-resistant prostate cancer. Journal of the National Cancer Institute, 2011, Nov-16, Volume: 103, Issue:22 Topics: Androstenes; Androstenols; Angiogenesis Inhibitors; Anilides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Atrasentan; Benzamides; Bevacizumab; Biomarkers, Tumor; Bone Remodeling; Cancer Vaccines; Clinical Trials as Topic; Clusterin; Dasatinib; Denosumab; Endothelin-1; Humans; Immunotherapy; Indoles; Ipilimumab; Male; Mice; Mice, SCID; Molecular Targeted Therapy; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Pyrimidines; Pyrroles; Pyrrolidines; RANK Ligand; Receptor Cross-Talk; Receptors, Androgen; Signal Transduction; Sunitinib; Taxoids; Thiazoles; Tissue Extracts; Treatment Failure; Tumor Microenvironment; Xenograft Model Antitumor Assays	2011

Article

Year

Novel therapies for metastatic castrate-resistant prostate cancer.

Journal of the National Cancer Institute, 2011, Nov-16, Volume: 103, Issue:22

Topics: Androstenes; Androstenols; Angiogenesis Inhibitors; Anilides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Atrasentan; Benzamides; Bevacizumab; Biomarkers, Tumor; Bone Remodeling; Cancer Vaccines; Clinical Trials as Topic; Clusterin; Dasatinib; Denosumab; Endothelin-1; Humans; Immunotherapy; Indoles; Ipilimumab; Male; Mice; Mice, SCID; Molecular Targeted Therapy; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Pyrimidines; Pyrroles; Pyrrolidines; RANK Ligand; Receptor Cross-Talk; Receptors, Androgen; Signal Transduction; Sunitinib; Taxoids; Thiazoles; Tissue Extracts; Treatment Failure; Tumor Microenvironment; Xenograft Model Antitumor Assays

2011